Skip to main navigation Skip to search Skip to main content

"Paclitaxel or no Paclitaxel in second-line, that's the question" in ovarian cancer patients who relapse after a prolonged platinum-free interval

  • J.B Vermorken
  • , R. Huijskens
  • , R.E.N. van Rijswijk
  • , K. Hoekman
  • , RHM Verheijen
  • , P. Kenemans
  • , H.M. Pinedo

Research output: Contribution to conference › Abstract › Other research output

Original languageEnglish
Publication statusPublished - 1994
Event8th NCI-EORTC Symposium on New Drugs in Cancer Therapy - Amsterdam, Netherlands
Duration: 23 Sept 1994 → …

Conference

Conference8th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Country/TerritoryNetherlands
CityAmsterdam
Period23/09/94 → …

Cite this